Veritas Investment Management LLP increased its position in Xylem Inc (NYSE:XYL) by 2.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 777,400 shares of the industrial products company’s stock after purchasing an additional 22,275 shares during the period. Xylem makes up approximately 5.4% of Veritas Investment Management LLP’s holdings, making the stock its 9th biggest position. Veritas Investment Management LLP owned 0.43% of Xylem worth $61,881,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the stock. Commonwealth Bank of Australia raised its position in Xylem by 27.3% in the 2nd quarter. Commonwealth Bank of Australia now owns 2,502 shares of the industrial products company’s stock worth $207,000 after buying an additional 536 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in Xylem by 48.8% in the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,438 shares of the industrial products company’s stock worth $204,000 after buying an additional 800 shares during the last quarter. Carnegie Capital Asset Management LLC purchased a new position in Xylem in the 2nd quarter worth about $356,000. Ardevora Asset Management LLP raised its position in Xylem by 3.4% in the 2nd quarter. Ardevora Asset Management LLP now owns 513,400 shares of the industrial products company’s stock worth $42,941,000 after buying an additional 16,800 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new position in Xylem in the 2nd quarter worth about $250,000. Institutional investors own 84.81% of the company’s stock.
Several equities research analysts have recently commented on the stock. Zacks Investment Research lowered shares of Xylem from a “hold” rating to a “sell” rating and set a $82.00 price target for the company. in a research report on Monday, October 14th. Cfra lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. Credit Suisse Group set a $78.00 price target on shares of Xylem and gave the company a “hold” rating in a research report on Friday, November 1st. Royal Bank of Canada set a $79.00 price target on shares of Xylem and gave the company a “buy” rating in a research report on Friday, November 1st. Finally, ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $82.30.
In related news, Director Markos I. Tambakeras sold 2,860 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $78.95, for a total value of $225,797.00. Following the completion of the sale, the director now directly owns 43,530 shares of the company’s stock, valued at approximately $3,436,693.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kenneth Napolitano sold 5,000 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $77.49, for a total transaction of $387,450.00. Following the completion of the sale, the senior vice president now directly owns 46,228 shares of the company’s stock, valued at $3,582,207.72. The disclosure for this sale can be found here. Insiders sold a total of 16,959 shares of company stock valued at $1,313,986 over the last three months. 0.85% of the stock is currently owned by insiders.
Shares of NYSE XYL traded down $1.52 during midday trading on Monday, hitting $75.81. 914,120 shares of the company’s stock traded hands, compared to its average volume of 838,117. Xylem Inc has a 1 year low of $60.65 and a 1 year high of $85.67. The stock has a market capitalization of $14.35 billion, a price-to-earnings ratio of 26.32, a price-to-earnings-growth ratio of 1.60 and a beta of 1.18. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.15 and a current ratio of 1.55. The firm has a fifty day moving average of $78.69 and a 200 day moving average of $78.88.
Xylem (NYSE:XYL) last released its quarterly earnings results on Thursday, October 31st. The industrial products company reported $0.82 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.82. Xylem had a net margin of 9.65% and a return on equity of 19.14%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the firm earned $0.77 EPS. The business’s revenue for the quarter was up .7% compared to the same quarter last year. On average, equities analysts anticipate that Xylem Inc will post 3.02 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 5th. Investors of record on Thursday, October 31st will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 1.27%. The ex-dividend date is Wednesday, October 30th. Xylem’s dividend payout ratio is 33.33%.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Read More: What is the quiet period?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.